Prussian Blue Derived Nanoporous Iron Oxides as Anticancer Drug Carriers for Magnetic‐Guided Chemotherapy

New nanoporous iron oxide nanoparticles with superparamagnetic behavior were successfully synthesized from Prussian blue (PB) nanocubes through a thermal conversion method and applied to the intracellular drug‐delivery systems (DDS) of bladder cancer cells (i.e., T24) with controlled release and magnetic guiding properties. The results of the MTT assay and confocal laser scanning microscopy indicate that the synthesized iron oxide nanoparticles were successfully uptaken by T24 cells with excellent biocompatibility. An anticancer drug, that is, cisplatin, was used as a model drug, and its loading/release behavior was investigated. The intracellular drug delivery efficiency was greatly enhanced for the cisplatin‐loaded, PB‐derived, magnetic‐guided drug‐delivery system compared with the non‐drug case. The synthesized nanomaterials show great potential as drug vehicles with high biocompatibility, controlled release, and magnetic targeting features for future intracellular DDS.     

Chondroitin/polypyrrole nanocomposite hydrogels for the accurate release of 5-fluorouracil by electrical stimulation

The development of electro-stimulated drug release devices is an innovative approach to attain the drug delivery in accurate doses at target sites in a programmed manner. In this work, novel electroactive nanocomposite hydrogels were prepared by encapsulating green-synthesized polypyrrole (PPy) colloids within chondroitin sulfate (CS) networks during the self-crosslinking of CS via N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide chemistry. The structural and morphological properties of CS/PPy hydrogels were studied by Fourier-transformed infrared spectroscopy, scanning electron microscopy, and swelling kinetic measurements. The chemotherapeutic agent 5-fluorouracil (5-FU) was loaded into CS/PPy samples by hydrogel swelling method, or alternatively, by pre-incubating the drug in polymer mixture before crosslinking. Different electrical stimulations can be used to switch ON and accurately tune the 5-FU delivery from GG/PPy hydrogels. A single pulse potential of 5 V switched on the drug delivery up to 90% from nanocomposite hydrogel, in contrast to the low 5-FU amount released in a passive form (< 20%). PPy electroactive behavior played a determining role as the main driving force in 5-FU release activation. Cytotoxicity of hydrogels with and without 5-FU was examined in normal and cancer cells. Considering the high cytotoxicity of 5-FU, the ON/OFF 5-FU release patterns evidenced the potential of CS/PPy hydrogels for electrically controlled drug delivery in implantable or transdermal drug release devices.     

Towards site-specific nanoparticles for drug delivery application: preparation,characterization and release performance

Due to the uncontrollable drug release, traditional chemotherapies could cause great side-effects and are detrimental to normal tissue or organs. Therefore, to avoid those side-effects, drug delivery system (DDS) which is capable of releasing drug molecules at target area with controllable rate according to the development of the disease or to certain functions of the organism/biological rhythm, has attracted especially focus in recent years. In this research, we devoted our efforts in constructing a core–shell nanocomposite to meet the above requirements. The superparamagnetic Fe₃O₄ nanoparticles were chosen as the core to introduce the magnetic guiding as well as site-specific properties in this novel drug carrier. The core was further encapsulated by silica-based molecular sieve MCM-41 (briefly denoted as MS in this research), which was consisted by immense highly ordered hexagonal tunnels to offer plenty cavity for molecules of drug. A light stimuli-responsive ligand, which is a derivative from light-responsive precursor 4,5-diazafluoren-9-one (indicated in the paper as DAFO), was further connected to the MCM-41 tunnels. The ligand can be excited by light and will flip over, making the tunnels of MCM-41 switch from close to open with light on and light off. The nanocomposite thus became capable of releasing drug molecules at certain wavelength of light. In the final, the nanoparticles were tested via SEM/TEM, XRD, FT-IR spectra, thermogravimetry and N₂ adsorption/desorption to verify the structure. The MTT testing of our nanocomposite reveals no obvious cytotoxicity with non-morbid L929 murine fibroblast cells line, indicating that it could be used as a DDS candidate. The cargo releasing behaviors were studied on cytarabine loaded composite: DAFO@MS@Fe₃O₄ in simulated body fluids.     

Properties of a Graphene Oxide-Balofloxacin Composite and Its Effect on Bacteriostasis

A novel graphene oxide-balofloxacin nanocomposite was synthesized, and the loading and release behavior of fluorescent antibacterial balofloxacin on graphene oxide was investigated. The surface morphologies of the nanocomposite were evaluated using transmission electron microscopy and fluorescence microscopy, and the amount of balofloxacin loaded on graphene oxide reached 160.3 mg/g at the initial balofloxacin concentration of 8.51 µg/ml. The graphene oxide and balofloxacin nanocomposite showed the advantage of a longer release time than many current developed nanoscaled drug carriers, which was probably due to the hydrogen bonding interaction between graphene oxide and balofloxacin. The study of the release liquid of e. coli in vitro bacteriostasis suggests that the graphene oxide-balofloxacin nanocomposite has a superior effect against e. coli.     

Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer

Nanoparticles have widely been studied in drug delivery research for targeting and controlled release. The aim of this article is application of nanoparticles as an inhalable agent for treatment of lung cancer. To deposit effectively deep the particles in the lungs, the PLGA nanoparticles loaded with the anticancer drug 6-{[2-(dimethylamino)ethyl]amino}-3-hydroxyl-7H-indeno[2,1-c]quinolin-7-one dihydrochloride (TAS-103) were prepared in the form of nanocomposite particles. The nanocomposite particles consist of the complex of drug-loaded nanoparticles and excipients. In this study, the anticancer effects of the nanocomposite particles against the lung cancer cell line A549. Also, the concentration of TAS-103 in blood and lungs were determined after administration of the nanocomposite particles by inhalation to rats.TAS-103-loaded PLGA nanoparticles were prepared with 5% and 10% of loading ratio by spray drying method with trehalose as an excipient. The 5% drug-loaded nanocomposite particles were more suitable for inhalable agent because of the sustained release of TAS-103 and higher FPF value. Cytotoxicity of nanocomposite particles against A549 cells was higher than that of free drug.When the nanocomposite particles were administered in rats by inhalation, drug concentration in lung was much higher than that in plasma. Furthermore, drug concentration in lungs administered by inhalation of nanocomposite particles was much higher than that after intravenous administration of free drug.From these results, the nanocomposite particle systems could be promising for treatment of lung cancer.     

Au(III) complexes loaded pH‐responsive magnetic nanogels for cancer therapy

A novel pH‐responsive magnetic nanogels were developed with the aim of targeted delivering and simultaneously releasing of newly synthesized Au(III)‐based anticancer drug, Au(1,7‐Phen)Br₃. The obtained nanogels were characterized by FT‐IR, DLS, EDAX, TEM, XRD, ICP‐Ms and MRI. The TEM images showed that the nanogels had a spherical shape with a mean diameter of 20 nm. The in vitro release studies of Au (III)‐loaded nanogels showed a pH‐triggered controlled release of drugs. The in vitro cytotoxicity assay of samples to human cervical cancer HeLa cell lines indicated that the Au(III)‐loaded magnetic nanogels exert higher cytotoxicity in comparison with free Au(III) complex. Fluorescent microscope images indicated that these magnetic nanogels possessed notable cell specific targeting in vitro in the presence of an external magnetic field. The results show that this superparamagnetic nanocarrier is a promising candidate for inhibiting growth of tumor cells.     

Flexible Magnetic Nanoparticles–Reduced Graphene Oxide Composite Membranes Formed by Self‐Assembly in Solution

A facile and robust route for the pre‐synthesized Fe₃O₄ nanoparticles (NPs) exclusively assembled on both sides of reduced graphene oxide (RGO) sheets with tunable density forming two‐dimensional NPs composite membranes is developed in solution. The assembly is driven by electrostatic attraction, and the nanocomposite sheets display considerable mechanical robustness, such as it can sustain supersonic and solvothermal treatments without NPs falling off, also, can freely float in solution and curl into a tube. The obtained two‐dimensional composite grain membranes exhibit superparamagnetic behavior at room temperature but responds astutely to an external magnetic field. In addition, these magnetic composite membranes show an enhanced absorption capability for microwaves. The grain sheets are attractive for biomedical, sensors, environmental applications and electric‐magnetic devices benefited from large surfaces, high magnetization moment, and superparamagnetic properties. The effective integration of oxide nanocrystals on RGO sheets provides a new way to design semiconductor–carbon nanocomposites for nanodevices or catalytic applications.     

Magnetic Hybrid Wax Nanocomposites as Externally Controlled Theranostic Vehicles: High MRI Enhancement and Synergistic Magnetically Assisted Thermo/Chemo Therapy

To fight against cancer, smarter drugs and drug delivery systems are required both to boost the efficiency of current treatments while reducing deleterious side effects, and combine diagnosis/monitoring with therapy (theranosis) in the search for the final goal of personalized medicine. This work presents the design, preparation, and proof-of-principle validation of a novel hybrid organic–inorganic nanocomposite joining together non-invasive imaging capabilities through magnetic resonance imaging and externally actuated therapeutic properties through a combination of chemo- and thermotherapy. The lipidic matrix of the nanocomposite was composed of carnauba wax, which was simultaneously dual loaded with magnetite nanoparticles and the anticancer drug Oncocalyxone A. Obtained formulations were fully characterized and showed outstanding performances as T₂-contrast agents in magnetic resonance imaging (r₂>800 mm ⁻¹ s⁻¹), heat generating sources in magnetic hyperthermia (specific absorption rate, SAR>200 W g⁻¹_Fe), and magnetically responsive drug delivery vehicles. The potential of the designed formulations as theranostic agents was validated in vitro and results indicated a synergistic thermo/chemotherapeutic effect derived from heat generation and controlled drug delivery to cancer growth. Thereby, this external control over the drug delivery profile and the integrated imaging capability open the door to personalized cancer medicine and real-time monitoring of tumor progression.     

Preparation of chitosan–silica/PCL composite membrane as wound dressing with enhanced cell attachment

In the present study, the asymmetrical polycaprolactone membranes were synthesized using phase inversion method and modified by addition of Pluronic (F‐127) and sodium hydroxide treatment to improve the cell attachment. The chemical structure, physical properties and mechanical behavior of the membranes as well as cell attachment and proliferation on them were characterized and compared to determine the appropriate membrane used in wound dressing fabrication. Then, a composite membrane as wound dressing capable of drug controlled‐release was prepared composed of two merged layers: an asymmetrical poly(ε‐caprolactone) layer coated with a drug‐loaded chitosan – silica matrix. Drug release behavior and biocompatibility of the final system were evaluated. The results showed that the polycaprolactone modified membrane provides appropriate properties to expand fibroblast cell adhesion and proliferation. This in‐vitro study also showed that the controlled‐release composite wound dressing was developed with approximately 70% cumulative release rate, which provided a porous substrate to support skin cells. Copyright © 2017 John Wiley & Sons, Ltd.     

Tannic acid-coated zeolite Y nanoparticles as novel drug nanocarrier with controlled release behavior and anti-protozoan activity against Trichomonas gallinae

In this study, a pH-sensitive drug release system was prepared by zeolite Y nanoparticles and tannic acid. Zeolite Y nanoparticles were synthesized via hydrothermal synthesis of colloidal suspensions and after that, were coated with tannic acid. In order to evaluate its performance, metronidazole as an anti-protozoan drug was loaded into nanocarriers via immersing method to study the in-vitro drug delivery behavior. This nanocomposite carriers represented pH-sensitive behavior and had more and faster release in acidic medium. In-vitro effects of metronidazole-loaded nanoparticles was measured against Trichomonas gallinae trophozoites in Trypticase Yeast extract Maltose medium. The results suggested that metronidazole-loaded and tannic acid-modified zeolite Y nanoparticles could be a potential anti-trichomonal agent.     

Fabrication of novel multihollow superparamagnetic magnetite/polystyrene nanocomposite microspheres via water-in-oil-in-water double emulsions

We herein present a novel and simple synthetic strategy for fabricating multihollow superparamagnetic magnetite/polystyrene nanocomposite microspheres via water-in-oil-in-water double emulsions. Amphipathic magnetite nanoparticles surface-modified with oleic acid act as an oil-soluble emulsifier and sodium dodecyl sulfate acts as a water-soluble surfactant in the system. The final products were thoroughly characterized by X-ray powder diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy, and field-emission scanning electron microscopy, which showed the formation of multihollow magnetite/polystyrene nanocomposite microspheres. Preliminary results of magnetic properties of multihollow magnetite/polystyrene microspheres were reported. The effect of the content of amphipathic magnetite nanoparticles on the morphology of nanocomposite microspheres was studied. Furthermore, the mechanism of formation of multihollow magnetic nanocomposite microspheres was also discussed.     

Core–Shell Hollow Microspheres of Magnetic Iron Oxide@Amorphous Calcium Phosphate: Synthesis Using Adenosine 5′‐Triphosphate and Application in pH‐Responsive Drug Delivery

Drug nanocarriers with magnetic targeting and pH‐responsive drug‐release behavior are promising for applications in controlled drug delivery. Magnetic iron oxides show excellent magnetism, but their application in drug delivery is limited by low drug‐loading capacity and poor control over drug release. Herein, core–shell hollow microspheres of magnetic iron oxide@amorphous calcium phosphate (MIO@ACP) were prepared and investigated as magnetic, pH‐responsive drug nanocarriers. Hollow microspheres of magnetic iron oxide (HMIOs) were prepared by etching solid MIO microspheres in hydrochloric acid/ethanol solution. After loading a drug into the HMIOs, the drug‐loaded HMIOs were coated with a protective layer of ACP by using adenosine 5′‐triphosphate (ATP) disodium salt (Na₂ATP) as stabilizer, and drug‐loaded core–shell hollow microspheres of MIO@ACP (HMIOs/drug/ACP) were obtained. The as‐prepared HMIOs/drug/ACP drug‐delivery system exhibits superparamagnetism and pH‐responsive drug‐release behavior. In a medium with pH 7.4, drug release was slow, but it was significantly accelerated at pH 4.5 due to dissolution of the ACP shell. Docetaxel‐loaded core–shell hollow microspheres of MIO@ACP exhibited high anticancer activity.     

Effect of polyol structure on the properties of the resultant magnetic polyurethane elastomer nanocomposites

In this study, two types of magnetic polyurethane (PU) elastomer nanocomposites using polycaprolactone (PCL) and polytetramethylene glycol (PTMG) as polyols were synthesized by incorporating thiodiglycolic acid surface modified Fe₃O₄ nanoparticles (TSM‐Fe₃O₄) into PU matrices through in situ polymerization method. TSM‐Fe₃O₄ nanoparticles were prepared using in situ coprecipitation method in alkali media and were characterized by X‐ray diffraction, Fourier Transform Infrared Spectrophotometer, Transmission Electron Microscopy, and Vibrating Sample Magnetometer. The effects of PCL and PTMG polyols on the properties of the resultant PUs were studied. The morphology and dispersion of the nanoparticles in the magnetic nanocomposites were studied by Scanning Electron Microscope. It was observed that dispersion of nanoparticles in PTMG‐based magnetic nanocomposite was better than PCL‐based magnetic nanocomposite. Furthermore, the effect of polyol structure on thermal and mechanical properties of nanocomposite was investigated by Thermogravimetric Analysis and Dynamic Mechanical Thermal Analysis. A decrease in the thermal stability of magnetic nanocomposites was found compared to pure PUs. Furthermore, DMTA results showed that increase in glass transition temperature of PTMG‐based magnetic nanocomposite is higher than PCL‐based magnetic nanocomposite, which is attributed to better dispersion of TSM‐Fe₃O₄ nanoparticles in PTMG‐based PU matrix. Additionally, magnetic nanocomposites exhibited a lower level of hydrophilicity compared to pure PUs. These observations were attributed to the hydrophobic behavior of TSM‐Fe₃O₄ nanoparticles. Moreover, study of fibroblast cells interaction with magnetic nanocomposites showed that the products can be a good candidate for biomedical application. Copyright © 2013 John Wiley & Sons, Ltd.     

Encapsulation and release of biomolecules from Ca-P/PHBV nanocomposite microspheres and three-dimensional scaffolds fabricated by selective laser sintering

This study focused on the fabrication of calcium phosphate (Ca-P)/poly(hydroxybutyrate-co-hydroxyvalerate) (PHBV) nanocomposite scaffolds loaded with biomolecules using the selective laser sintering (SLS) technique and their evaluation. Ca-P/PHBV nanocomposite microspheres loaded with bovine serum albumin (BSA) as the model protein were fabricated using the double emulsion solvent evaporation method. The encapsulation efficiency of BSA in PHBV polymer microspheres and Ca-P/PHBV nanocomposite microspheres were 18.06 ± 0.86% and 24.51 ± 0.60%, respectively. The BSA loaded Ca-P/PHBV nanocomposite microspheres were successfully produced into three-dimensional porous scaffolds with good dimensional accuracy using the SLS technique. The nanocomposite microspheres served as protective carriers and maintained the bioactivity of BSA during SLS. The effects of SLS parameters such as laser power and scan spacing on the encapsulation efficiency of BSA in the scaffolds and in vitro BSA release were studied. An initial burst release was observed, which was followed by a slow release of BSA. After 28-day release, The PHBV matrix was slightly degraded after 28-day in vitro release study. It was shown that nanocomposite scaffolds with controlled architecture obtained via SLS could be incorporated with biomolecules, enhancing them with more functions for bone tissue engineering application or making them suitable for localized delivery of therapeutics.     

Long-Term Antibacterial Film Nanocomposite Incorporated with Patchouli Essential Oil Prepared by Supercritical CO2 Cyclic Impregnation for Wound Dressing

Biocompatible skin wound dressing materials with long-term therapeutic windows and anti-infection properties have attracted great attention all over the world. The cooperation between essential oil and non-toxic or bio-based polymers was a promising strategy. However, the inherent volatility and chemical instability of most ingredients in essential oils make the sustained pharmacological activity of essential oil-based biomaterials a challenge. In this study, a kind of film nanocomposite loaded with patchouli essential oil (PEO-FNC) was fabricated. PEO-loaded mesoporous silica nanoparticles (PEO-MSNs) with drug load higher than 40 wt% were firstly prepared using supercritical CO₂ cyclic impregnation (SCCI), and then combined with the film matrix consisting of polyvinyl alcohol and chitosan. The morphology of PEO-MSNs and PEO-FNC was observed by transmission and scanning electron microscope. The mechanical properties, including hygroscopicity, tensile strength and elongation at break (%), were tested. The release behavior of PEO from the film nanocomposite showed that PEO could keep releasing for more than five days. PEO-FNC exhibited good long-term (>48 h) antibacterial effect on Staphylococcus aureus and non-toxicity on mouse fibroblast (L929 cells), making it a promising wound dressing material.     

Encapsulation of doxorubicin in magnetic‐polymer hybrid colloidal particles of Eudragit E100 and their hyperthermia and drug release studies

Water‐soluble magnetite Fe₃O₄ nanoparticles were synthesized by coprecipitation that exhibit spherical morphology and superparamagnetic behavior with a saturation magnetization of 46 emu/g. These nanoparticles were coated with amino methacrylate copolymer (Eudragit E100) along with encapsulation of Doxorubicin drug under the action of sonication via a double emulsion solvent evaporation method. The prepared magnetic colloids were evaluated for particle size, surface morphology, surface charge, drug loading capacity, and entrapment efficiency. The drug release studies indicated the sustained release of drug of 92% in 24 hours at physiological pH of 7.4 and drug release kinetics followed first order. The prepared nanoparticles and their colloids were also investigated for magnetic hyperthermia and specific absorption rate values were found to be 2.41, 2.71, and 4.28 W/g at 259, 327, and 518 kHz, respectively. The developed magnetic colloids have the potential to perform controlled hyperthermia and drug release to the target sites.     

Modification of Dietary Fiber Psyllium with Poly(vinyl pyrrolidone) through Network Formation for Use in Slow Drug Delivery Application

In view of the pharmacological importance of dietary fibre, psyllium, to cure the constipation and diverticulitis, in the present study, an attempt has been made to modify psyllium polysaccharide with PVP to develop the hydrogel meant for slow and controlled drug delivery systems. The polymer was characterized by SEMs, FTIR, XRD, TGA and swelling studies. Swelling of hydrogels and drug (ciprofloxacin) release profile from the drug loaded hydrogels were determined for the evaluation of the swelling/release mechanism. Biomedical properties; biocompatibility and mucoadhesion of the hydrogels, were also studied. Swelling of the hydrogels and release of drugs from drug loaded hydrogels occurred through non-Fickian diffusion mechanism. Here it is pertinent to mention that both psyllium husk polysaccharide and antibiotic drug ciprofloxacin are used for gastrointestinal tract (GIT) problem, especially in case of diverticulitis. Hence, degradation of the polymer matrix and release of drug may exert the synergic effect and the present drug delivery system may act with enhanced potential.     

Ultrasonic-assisted synthesis of PMMA/Ni0.5Zn0.5Fe2O4 nanocomposite in mixed surfactant system

PMMA/Ni_0.5Zn_0.5Fe₂O₄ nanocomposite with superparamagnetic behavior was synthesized by in situ emulsion polymerization of methylmethacrylate (MMA) monomer in the presence of Ni_0.5Zn_0.5Fe₂O₄ colloidal suspension assisted by ultrasonic irradiation. The obtained samples were characterized by X-ray diffraction (XRD), Fourier transform infrared spectra (FT-IR), transmission electron microscopy (TEM) and vibrating sample magnetometer (VSM). XRD and FT-IR spectra confirmed the formation of PMMA/Ni_0.5Zn_0.5Fe₂O₄ nanocomposite. TEM images showed that Ni_0.5Zn_0.5Fe₂O₄ nanoparticles with the particle sizes of about 12 nm were well dispersed in the polymer matrix. The nanocomposite at room temperature exhibited superparamagnetic behavior under applied magnetic field. The formation mechanism of PMMA/Ni_0.5Zn_0.5Fe₂O₄ nanocomposite was proposed as well.     

Fabrication and characterization of UV‐crosslinkable thermoresponsive composite fibers with magnetic properties

Crosslinking magnetic thermoresponsive composite (MTC) fiber mats were fabricated by electrospinning process and followed by UV curing. Thermoresponsive poly‐(N‐isopropylacrylamide) (PNIPAAm) and magnetic Fe₃O₄ were firstly synthesized by redox‐initiated polymerization and co‐precipitation, respectively. A crosslinking agent (dipentaerythritol hexylacrylate) and photoinitiator for providing crosslinking ability were then mixed with PNIPAAm and Fe₃O₄ in ethanol as the electrospinning solution. After electrospinning and subsequent UV irradiation, the MTC fiber mats were thus obtained. Thermoresponsivity of the MTC fibers was measured by both DSC and swelling test. MTC fiber mat exhibited better water‐absorption capability and thermoresponsivity than corresponding film. Morphological analysis was observed by SEM and TEM, and the magnetic property was measured by SQUID. The thermoresponsive magnetic behavior of MTC fiber mat in water was observed under various temperatures and magnetic fields. Vitamin B₁₂ used as a model drug was loaded in the MTC fiber mats and the drug‐release behavior was then studied. © 2015 Wiley Periodicals, Inc. J. Polym. Sci., Part A: Polym. Chem. 2015 , 53, 2152–2162     

Synthesis and characterization of PEGylated iron and graphene oxide magnetic composite for curcumin delivery

Nowadays, nanostructures have been given significant attention in medical and biological fields. Among these nanostructures, graphene oxide (GO) has been widely used in drug delivery systems, because of its unique properties, and the ability to connect to other nanostructures such as magnetic nanoparticles (NPs) as well as polymers by its functional groups. In this research, first, GO was prepared by exfoliating graphite according to the modified Hummer’s method, and then the Fe₃O₄ NPs were synthesized by a simple co-precipitation method on GO nanosheets. In the next step, with the help of the ethyl-3-(3-dimethylaminopropyl) carbodiimide/N-hydroxysuccinimide coupling reagents, the polyethylene glycol (PEG) polymer was bonded to the GO-Fe₃O₄ nanocomposite. Finally, anti-cancer drug, curcumin (Cur) was loaded onto the nanocomposite and the Cur loading ratio was measured at about 8%. The samples were evaluated using Fourier transform-infrared, differential scanning calorimtery, vibrating-sample magnetometry, atomic force microscopy and dynamic light scattering techniques. The results show that the prepared nanocomposite is an appropriate candidate for biomedical applications.